SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-21-008205
Filing Date
2021-08-16
Accepted
2021-08-16 17:23:18
Documents
2
Period of Report
2021-08-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 1745
2 EX-24 ex24rubius_v2.htm EX-24.HTM 6860
  Complete submission text file 0001179110-21-008205.txt   9996
Mailing Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139 617-679-9600
Rubius Therapeutics, Inc. (Issuer) CIK: 0001709401 (see all company filings)

IRS No.: 042688109 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O RUBIUS THERAPEUTICS, INC. 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139
Business Address
Appelhans Dannielle (Reporting) CIK: 0001874962 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38586 | Film No.: 211179926